The re-emergence of tuberculosis.
Porter
J D
JD
London School of Hygiene and Tropical Medicine, University of London, U.K.
McAdam
K P
KP
D000293:Adolescent; D000328:Adult; D000995:Antitubercular Agents / Q000191:economics / Q000600:supply & distribution / Q000627:therapeutic use; D001428:Bacterial Vaccines; D015897:Comorbidity; D003362:Cost-Benefit Analysis; D003906:Developing Countries; D004059:Diffusion of Innovation; D005544:Forecasting; D014943:Global Health; D015658:HIV Infections / Q000150:complications / Q000453:epidemiology* / Q000517:prevention & control*; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000276:immunology*; D009874:Operations Research; D011322:Primary Prevention / Q000191:economics / Q000379:methods; D011634:Public Health / Q000191:economics / Q000379:methods*; D012106:Research; D012720:Severity of Illness Index; D018088:Tuberculosis, Multidrug-Resistant / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control*; D014481:United States / Q000453:epidemiology
D000995:Antitubercular Agents; D001428:Bacterial Vaccines